perillyl alcohol has been researched along with Colorectal Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jin, X; Lee, JJ; Li, J; Li, X; Ma, J; Mi, C; Piao, LX; Wang, KS; Xu, GH | 1 |
| Bailey, H; Berlin, J; Kolesar, J; Meadows, SM; Mulkerin, D; Thomas, JP; Warren, D | 1 |
1 trial(s) available for perillyl alcohol and Colorectal Neoplasms
| Article | Year |
|---|---|
Phase II trial of perillyl alcohol in patients with metastatic colorectal cancer.
Topics: Administration, Oral; Adult; Aged; Antineoplastic Agents; Colorectal Neoplasms; Disease Progression; Dose-Response Relationship, Drug; Female; Humans; Male; Middle Aged; Monoterpenes; Neoplasm Metastasis; Treatment Outcome | 2002 |
1 other study(ies) available for perillyl alcohol and Colorectal Neoplasms
| Article | Year |
|---|---|
Perillyl alcohol efficiently scavenges activity of cellular ROS and inhibits the translational expression of hypoxia-inducible factor-1α via mTOR/4E-BP1 signaling pathways.
Topics: Adaptor Proteins, Signal Transducing; Animals; Antineoplastic Agents; Cell Cycle Proteins; Colorectal Neoplasms; Free Radical Scavengers; HCT116 Cells; HeLa Cells; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Male; Mice; Mice, Inbred BALB C; Mice, Nude; Monoterpenes; Phosphoproteins; Protein Biosynthesis; Reactive Oxygen Species; Signal Transduction; TOR Serine-Threonine Kinases; Tumor Burden; Xenograft Model Antitumor Assays | 2016 |